[Analysis of therapeutical effectiveness in 35 cases of acute leukemia with therapy of Chinese integrated medicine]

Zhongguo Zhong Xi Yi Jie He Za Zhi. 1995 Nov;15(11):643-5.
[Article in Chinese]


Thirty-five cases of acute leukemia were treated with methods of Chinese integrated medicine (CIM), i.e. in the CIM group, in which the complete remission rate, partial remission rate and total remission rate were 68.5%, 20.0% and 88.5%, respectively; while those in the random control group were 42.7%,20% and 62.7%, respectively. The comparison between the two groups showed a significant difference(P < 0.05). The patients' survival period in CIM group of 1,3,5 and above 5 years was shown in 20, 12, 7 and 5 cases, but in the control group, 9,5,0 and 0 cases, respectively. The comparison between the two groups also showed an obvious difference (P < 0.01), which demonstrates that the therapeutic effect was better in the CIM group and the patients' survival period was longer in the CIM group, too.

Publication types

  • Clinical Trial
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Diagnosis, Differential*
  • Drugs, Chinese Herbal / administration & dosage
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Male
  • Medicine, Chinese Traditional*
  • Middle Aged
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*


  • Antineoplastic Agents, Phytogenic
  • Drugs, Chinese Herbal